< Back to previous page
Researcher
Wim Robberecht
- Disciplines:Neurosciences, Biological and physiological psychology, Cognitive science and intelligent systems, Developmental psychology and ageing
Affiliations
- Laboratory for Neurobiology (VIB-KU Leuven) (Lab)
Member
From1 Jan 2012 → Today - Research Group Experimental Neurology (Division)
Member
From1 Oct 1999 → 31 Dec 2011
Projects
11 - 20 of 29
- STRENGTH : Survival, trigger and risk, epigenetic, environmental and genetic targets for motor neuron health.From1 Jan 2014 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
- Investigation of the pathogenic mechanism and identification of disease-modifying genes in FUS-induced amyotrophic lateral sclerosis (ALS).From1 Sep 2013 → 31 Dec 2017Funding: IWT personal funding - strategic basic research grants
- Creation of cell-specific models for TDP-43 associated ALS.From1 Sep 2012 → 31 Dec 2017Funding: IWT personal funding - strategic basic research grants
- The role of histon deacetylase 6 (HDAC6) in peripheral axonal neuropathies and amyotrophic lateral sclerosis (ALS).From1 Sep 2012 → 28 Mar 2018Funding: IWT personal funding - strategic basic research grants
- Wordkstation for high speed and resolution imaging of living animals by confocal multiphoton laser scanning microscopy.From28 Jun 2012 → 27 Dec 2018Funding: Hercules - Small and Medium size research infrastructure
- Functional role of Notch signaling in motor neurons, oligodendrocytes and ependymal stemcells during motor neuron degeneration in amyotrophic lateral sclerosis.From1 Jan 2012 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- Role of histone deacetylase 6 (HDAC6) in peripheral axonal neuropathies and in amyotrophic lateral sclerosis (ALS).From1 Jan 2012 → 31 Dec 2017Funding: FWO research project (including WEAVE projects)
- The zebrafish as model system to study the genetic causes and risk factors for amyotrophic lateral sclerosis (ALS).From22 Dec 2011 → 31 Dec 2014Funding: Nonprofit institution or equivalents
- The functional meaning of the Notch signaling cascade for neurodegeneration: a translational approach.From1 Sep 2011 → 10 Oct 2018Funding: IWT personal funding - strategic basic research grants
- Identifying modifying factors in stroke etiology and recoveryFrom1 Oct 2010 → 30 Sep 2012Funding: BOF - Other initiatives
Publications
1 - 10 of 198
- The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases(2023)
Authors: Wim Robberecht
- Telomere length analysis in amyotrophic lateral sclerosis using large-scale whole genome sequence data(2022)
Authors: Wim Robberecht, Philip Van Damme
- The SOD1-mediated ALS phenotype shows a decoupling between age of symptom onset and disease duration(2022)
Authors: Wim Robberecht, Philip Van Damme
- Structural variation analysis of 6,500 whole genome sequences in amyotrophic lateral sclerosis(2022)
Authors: Wim Robberecht, Philip Van Damme
- The Effect of SMN Gene Dosage on ALS Risk and Disease Severity(2021)
Authors: Wim Robberecht, Philip Van Damme
Pages: 686 - 697 - AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS(2021)
Authors: Elisabeth Rossaert, Sebastian Munck, Philip Van Damme, Matthew Holt, Ludo Van Den Bosch, Wim Robberecht
Pages: 508 - 519 - STING-Induced Inflammation - A Novel Therapeutic Target in ALS?(2021)
Authors: Philip Van Damme, Wim Robberecht
Pages: 765 - 767 - SCFD1 expression quantitative trait loci in amyotrophic lateral sclerosis are differentially expressed(2021)
Authors: Philip Van Damme, Wim Robberecht
- Exploration of the role of EphA4 in neurodegenerative diseases.(2020)
Authors: Lindsay Poppe, Wim Robberecht, Philip Van Damme
- Environmental enrichment during the chronic phase after experimental stroke promotes functional recovery without synergistic effects of EphA4 targeted therapy(2020)
Authors: Lindsay Poppe, Wim Robberecht, Robin Lemmens
Pages: 605 - 617
Patents
1 - 6 of 6
- Single domain antibodies against sod1 and their use in medicine (Inventor)
- Hdac inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- HDAC inhibitors to treat charcot-marie-tooth disease (Inventor)
- SINGLE DOMAIN ANTIBODIES AGAINST SOD1 AND THEIR USE IN MEDICINE (Inventor)
- USE OF EPHRIN TYPE-A RECEPTOR 4 SIGNALING INHIBITOR FOR TREATMENT OF MOTOR NEURON DISEASE CHOSEN FROM AMYOTROPHIC LATERAL SCLEROSIS AND SPINAL MUSCULAR ATROPHY (Inventor)